XML 81 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
Non-Controlling Interests - Spero Gyrase - Additional Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Noncontrolling Interest [Line Items]    
Common stock issued, aggregate fair value $ 221 $ 14,234
Research and development expense $ 51,440 $ 47,593